Sahlgrenska Universitetssjukhuset är Sveriges största sjukhus och ett av de större i norra Europa. Verksamheten hade en omsättning på 19,4 miljarder kronor 2021. Sjukhuset bildades den 1 januari 1997 när akutsjukhusen Sahlgrenska sjukhuset, Östra sjukhuset och Mölndals sjukhus slogs ihop.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Imcyse SA
2
Pfizer
2
Scandinavian Biopharma AB
1
Clinical Trials at CTC Sahlgrenska Universitetssjukhuset
During the past decade, CTC Sahlgrenska Universitetssjukhuset conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Chronic Kidney Disease
2021-04-27
2023-09-30
Recruiting
240
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CTC Sahlgrenska Universitetssjukhuset"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Göteborg University" with 1 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 1 trials as a collaborator and "Scandinavian CRO" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at CTC Sahlgrenska Universitetssjukhuset
According to Clinical.Site data, the most researched conditions in "CTC Sahlgrenska Universitetssjukhuset" are
"Type 1 Diabetes Mellitus" (2 trials), "Cardiovascular Disease" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "CTC Sahlgrenska Universitetssjukhuset" in a lesser frequency.
Clinical Trials Intervention Types at CTC Sahlgrenska Universitetssjukhuset
Most popular intervention types in "CTC Sahlgrenska Universitetssjukhuset" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BI 685509" (1 trials), "BI 690517" (1 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CTC Sahlgrenska Universitetssjukhuset
The vast majority of trials in "CTC Sahlgrenska Universitetssjukhuset" are
9 trials for "All" genders.
Clinical Trials Status at CTC Sahlgrenska Universitetssjukhuset
Currently, there are NaN active trials in "CTC Sahlgrenska Universitetssjukhuset".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in CTC Sahlgrenska Universitetssjukhuset,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CTC Sahlgrenska Universitetssjukhuset, 3 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".